SCHEMBL31651389

SCHEMBL31651389

CCCOc1ccc(S(=O)(=O)N2CCN(CCO[N+](=O)[O-])CC2)cc1-c1nc2c(CCC)cn(C)c2c(=O)[nH]1

nearest known ligand 0.92

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ PDE5A O76074 20/20 0.92

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20568085 1.00 PDE5A (0.92) PDE5A
SCHEMBL20567811 0.96 PDE5A (1.00) PDE5A
SCHEMBL20568425 0.96 PDE5A (1.00) PDE5A
SCHEMBL20567812 0.94 PDE5A (1.00) PDE5A
SCHEMBL31651380 0.94 PDE5A (1.00) PDE5A
SCHEMBL22028304 0.92 PDE5A (1.00) PDE5A
SCHEMBL20568055 0.90 PDE5A (0.88) PDE5A
SCHEMBL6484518 0.90 PDE5A (0.80) PDE5A
SCHEMBL6483207 0.90 PDE5A (0.88) PDE5A
SCHEMBL22028351 0.90 PDE5A (1.00) PDE5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3630769-B1 NOVEL DUAL MODE OF ACTION SOLUBLE GUANYLATE CYCLASE ACTIVATORS AND PHOSPHODIESTERASE INHIBITORS AND USES THEREOF TOPADUR PHARMA AG (CH) 2025-07-02 — — EP claimed
Send feedback